✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Supriya Lifescience Ltd.

SUPRIYA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹6,003 Cr.
P/E
32.91

Supriya Lifescience Ltd.

  • Supriya Lifescience
  • Acutaas Chemicals
  • Aether Industries
  • TJI Pharma - API & CRAMS

FAQs on Supriya Lifescience Ltd. Shareprice

Supriya Lifescience has given better returns compared to its competitors.
Supriya Lifescience has grown at ~63.86% over the last 2yrs while peers have grown at a median rate of 32.64%

Yes, Supriya Lifescience is expensive.
Latest PE of Supriya Lifescience is 32.91, while 3 year average PE is 25.53.
Also latest EV/EBITDA of Supriya Lifescience is 22.88 while 3yr average is 16.42.

View FAQ's On Business

Growth Table

  • Supriya Lifescience Ltd.
  • Acutaas Chemicals
  • Aether Industries

Balance Sheet

  • Supriya Lifescience Ltd.
  • Acutaas Chemicals
  • Aether Industries

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Supriya Lifescience Ltd.
  • Acutaas Chemicals
  • Aether Industries

Cash Flow

  • Supriya Lifescience Ltd.
  • Acutaas Chemicals
  • Aether Industries

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Supriya Lifescience Ltd.
  • Acutaas Chemicals
  • Aether Industries

Quarterly Results

  • Supriya Lifescience Ltd.
  • Acutaas Chemicals
  • Aether Industries

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Supriya Lifescience Ltd. Financials

Balance sheet of Supriya Lifescience is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Supriya Lifescience is increasing.
Latest net debt of Supriya Lifescience is -₹103.22 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹158.28 Crs.

The profit is oscillating.
The profit of Supriya Lifescience is ₹182 Crs for TTM, ₹188 Crs for Mar 2025 and ₹119 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Supriya Lifescience latest dividend payout ratio is 4.28% and 3yr average dividend payout ratio is 5.02%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech